We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

61 hedge funds and large institutions have $723M invested in Legend Biotech in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

22% more funds holding

Funds holding: 50 → 61 (+11)

0.35% more ownership

Funds ownership: 9.3% → 9.65% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

4% less capital invested

Capital invested by funds: $751M → $723M (-$27.8M)

Holders
61
Holders Change
+11
Holders Change %
+22%
% of All Funds
1.08%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
20
Increased
16
Reduced
16
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$22.5M
2
WP
Woodline Partners
California
+$12.4M
3
BG
Bellevue Group
Switzerland
+$12M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.85M
5
AA
ALPS Advisors
Colorado
+$6.87M

Top Sellers

1
VC
Vivo Capital
California
-$16.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.2M
3
TAMH
Taikang Asset Management (HK)
Hong Kong
-$8.15M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.98M
5
MICM
Matthews International Capital Management
California
-$5.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
$93K +$94.8K +3,294 New
UBS Group
52
UBS Group
Switzerland
$55K +$23.1K +802 +69%
Citigroup
53
Citigroup
New York
$18K +$18.4K +640 New
PCM
54
Penserra Capital Management
California
$13K +$14.1K +490 New
KFA
55
Krane Funds Advisors
New York
$11K +$11K +382 New
QCG
56
Quadrant Capital Group
Ohio
$6K – – –
S
57
SignatureFD
Georgia
$4K – – –
GAM
58
Gemmer Asset Management
California
$3K +$2.88K +100 New
Bank of America
59
Bank of America
North Carolina
$2K – – –
Macquarie Group
60
Macquarie Group
Australia
$2K +$29 +1 +2%
Daiwa Securities Group
61
Daiwa Securities Group
Japan
$1K +$1.15K +40 New
Wellington Management Group
62
Wellington Management Group
Massachusetts
– -$13.2M -426,484 Closed
TAMH
63
Taikang Asset Management (HK)
Hong Kong
– -$8.15M -263,903 Closed
CC
64
Casdin Capital
New York
– -$4.31M -139,661 Closed
Millennium Management
65
Millennium Management
New York
– -$4.04K -130,802 Closed
Norges Bank
66
Norges Bank
Norway
– -$735K -23,797 Closed
GGHC
67
Gilder Gagnon Howe & Co
New York
– -$518K -16,768 Closed
ECM
68
ExodusPoint Capital Management
New York
– -$231K -7,478 Closed
MFS
69
Mirabella Financial Services
United Kingdom
– -$205K -6,654 Closed
Wells Fargo
70
Wells Fargo
California
– -$12K -400 Closed
1 2
3

LEGN Hedge Fund Activity: Q4 2020 in Review

61 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q4 2020, worth a combined $723M — down 3.7% from $751M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new LEGN positions and 9 closed out — a net gain of 11 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Federated Hermes, adding an estimated $22.5M. The largest seller was Vivo Capital, cutting an estimated $16.6M.

  • 61 institutional investors held Legend Biotech (LEGN) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $723M of Legend Biotech stock for Q4 2020, down 3.7% quarter-over-quarter.
  • 20 funds opened new Legend Biotech positions in Q4 2020 and 9 closed out, a net change of +11 holders.
  • The largest Legend Biotech buyer in Q4 2020 was Federated Hermes, an estimated $22.5M added.
  • The largest Legend Biotech seller in Q4 2020 was Vivo Capital, an estimated $16.6M sold.

Based on aggregated 13F filings for Q4 2020.